# A Trial of Tegileridine Fumarate Lnjection for Prolonged Mechanical Ventilation Abirritation in the Intensive Care Unit (ICU)

> **NCT07372924** · PHASE2 · RECRUITING · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 120 (estimated)

## Conditions studied

- Abirritation in the ICU

## Interventions

- **DRUG:** Tegileridine Fumarate lnjection
- **DRUG:** Tegileridine Fumarate lnjection
- **DRUG:** Remifentanil Hydrochloride for Injection

## Key facts

- **NCT ID:** NCT07372924
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-24
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07372924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07372924, "A Trial of Tegileridine Fumarate Lnjection for Prolonged Mechanical Ventilation Abirritation in the Intensive Care Unit (ICU)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07372924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*